DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Biodel Inc. (BIOD)
« Back to company indexBIOD Chatter Timeline
Stock Ticker for BIOD
Most Active Tweeters for BIOD
| User | Tweets |
|---|---|
| @Allstocknews | 2 |
| @fintel_io | 1 |
| @Stock_News_Now | 1 |
Recent Tweets for BIOD
 |
@Stock_News_Now $BIOD: New SEC Filing for BIOD: Form SC 13G (No. 0001623632-19-000768): https://t.co/yy217bUmJP June 7th 2019, 2:06pm |
 |
@fintel_io Federated Investors Inc /pa/ has filed a new 13G, reporting 11.94% ownership in $BIOD - https://t.co/RWAFoYLV8j June 7th 2019, 1:06pm |
 |
@Allstocknews $BIOD New Form SC 13G for Albireo Pharma Inc From our Stock News Alerts App June 7th 2019, 1:06pm |
|
@Allstocknews $BIOD Data on Albireo’s Odevixibat Presented at 2019 European Society for Paediatric Gastroenterology, Hepato From our Stock News Alerts App June 7th 2019, 7:06am |
|
@Allstocknews $BIOD Albireo to Present at Investor Conferences in June From our Stock News Alerts App May 29th 2019, 7:05am |
|
@Allstocknews $BIOD Albireo Announces Data on Pediatric Cholestatic Liver Diseases to be Presented at the 2019 ESPGHAN Annu From our Stock News Alerts App May 23rd 2019, 7:05am |
|
@Allstocknews $BIOD New Form 10-Q for Albireo Pharma Inc From our Stock News Alerts App May 9th 2019, 10:05am |
|
@Stock_News_Now $BIOD: New SEC Filing for BIOD: Form 8-K (No. 0001104659-19-028015): https://t.co/KzK5CPyPTh May 9th 2019, 8:05am |
|
@Allstocknews $BIOD Albireo Reports First Quarter 2019 Financial Results From our Stock News Alerts App May 9th 2019, 7:05am |
|
@Allstocknews $BIOD Albireo to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast From our Stock News Alerts App May 2nd 2019, 8:05am |
|
@Allstocknews $BIOD New Form 424B3 for Albireo Pharma Inc From our Stock News Alerts App May 1st 2019, 4:05pm |
 |
@confcalltran Biodel Inc. just filed a prospectus, suggesting it plans to soon issue some securities https://t.co/ygowM6No9y $BIOD May 1st 2019, 4:05pm |
|
@Stock_News_Now $BIOD: New SEC Filing for BIOD: Form EFFECT (No. 9999999995-19-000929): https://t.co/AeYvnJmYeZ May 1st 2019, 6:05am |
|
@Allstocknews $BIOD New Form EFFECT for Albireo Pharma Inc From our Stock News Alerts App May 1st 2019, 6:05am |
|
@confcalltran Biodel Inc. Just Received a Notice of Effectiveness https://t.co/pK2BoLKLsq $BIOD May 1st 2019, 6:05am |
|
@Allstocknews $BIOD New Form DEFA14A for Albireo Pharma Inc From our Stock News Alerts App April 25th 2019, 4:04pm |
|
@Allstocknews $BIOD New Form DEF 14A for Albireo Pharma Inc From our Stock News Alerts App April 25th 2019, 4:04pm |
|
@Stock_News_Now $BIOD: New SEC Filing for BIOD: Form DEFA14A (No. 0001104659-19-023682): https://t.co/OaTNuMISKB April 25th 2019, 4:04pm |
 |
@ExecPayOrg Biodel CEO Ronald Cooper's 2018 pay jumps 46% to $3.6M https://t.co/iXsTw7jC5V $BIOD #execpay April 25th 2019, 4:04pm |
|
@Allstocknews $BIOD Albireo Presents Data on A4250 in Children with Biliary Atresia and Alagille Syndrome at The Internatio From our Stock News Alerts App April 13th 2019, 7:04am |
|
@Allstocknews $BIOD Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAF From our Stock News Alerts App April 11th 2019, 7:04am |
|
@Stock_News_Now $BIOD: New SEC Filing for BIOD: Form 8-K (No. 0001104659-19-019486): https://t.co/8nDFGVSqgg April 3rd 2019, 7:04am |
|
@confcalltran Entry into a Material Definitive https://t.co/vASgzAYXiw $BIOD April 3rd 2019, 6:04am |
|
@Allstocknews $BIOD Albireo to Present at Investor Conferences in April From our Stock News Alerts App April 1st 2019, 7:04am |
|
@Allstocknews $BIOD New Form 3 for Albireo Pharma Inc From our Stock News Alerts App March 27th 2019, 5:03pm |
|
@Allstocknews $BIOD Albireo to Present Clinical Data on A4250 in Alagille Syndrome and Biliary Atresia at The International From our Stock News Alerts App March 27th 2019, 9:03am |
|
@Allstocknews $BIOD Stock Quote Notification for Albireo Pharma Inc From our Stock News Alerts App March 26th 2019, 6:03pm |
|
@Allstocknews $BIOD Albireo Expands Executive Leadership Team with Appointment of Pamela Stephenson as Chief Commercial Of From our Stock News Alerts App March 21st 2019, 8:03am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.